What does RA-SE GENETICS do?

RA-SE GENETICS is a farm in Wielsbeke. Public Limited, started on 30 December 2002, 2 establishments.

What is the address of RA-SE GENETICS?

The registered office of RA-SE GENETICS is located at Zwaantjesstraat(O) 12, 8710 Wielsbeke.

Is RA-SE GENETICS still active?

Yes. According to the CBE (29 October 2026) RA-SE GENETICS is active, legal situation “Normale toestand”, started on 30 December 2002.

Is RA-SE GENETICS registered on Peppol?

Yes, RA-SE GENETICS is registered on the Peppol network with ID 0208:0479179703.

What is the enterprise number of RA-SE GENETICS?

The enterprise number of RA-SE GENETICS is BE0479179703.

When was RA-SE GENETICS founded?

RA-SE GENETICS was founded on 30 December 2002.

Who are the directors of RA-SE GENETICS?

According to the 2025 annual accounts, the directors of RA-SE GENETICS are: Dany Cornelis, Thomas Vanden Avenne, ARL Genetics, Geert Spincemaille, Adrian Philip Lawson.

Is RA-SE GENETICS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 December 2002; 5 annual accounts filed, latest fiscal year 2025; 5 directors known from the annual account; 2 establishments in the CBE.

How much profit did RA-SE GENETICS make in 2025?

RA-SE GENETICS posted a profit after taxes of € 21,459 in financial year 2025.

What is the revenue of RA-SE GENETICS?

As a small company, RA-SE GENETICS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 364,994.

How much does an employee at RA-SE GENETICS earn?

The average wage cost per full-time employee at RA-SE GENETICS was € 106,300 in 2025: staff costs of € 191,348 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does RA-SE GENETICS have?

According to the 2025 annual accounts, RA-SE GENETICS has 1.8 full-time equivalents (FTE).

RA-SE GENETICS (Public Limited) - Wielsbeke

Dossier RA-SE GENETICS, printed on 29 October 2026 from databakkes.be/en/0479179703/ra-se-genetics. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 18 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

RA-SE GENETICS from Wielsbeke, company number BE0479179703, closed financial year 2025 with a result of € 21,459 after tax. For that financial year RA-SE GENETICS recorded a gross margin of € 364,994 and equity of € -940,212. Compared with financial year 2024, the result moved from € 22,641 to € 21,459. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Caution

€ -940,212

▲ € 21,459 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 21,459

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,950

▲ € 9,812 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -1.7 million.

People and assets in 2025

Full-time equivalents

1.8

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 191,348

▼ 6% vs 2024

€ 106,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 44,127

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1.6 million

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 46,694

▲ 34% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,943 Gross margin 2022: € 123,943 First fiscal year in the series	€ 384,513 Gross margin 2023: € 384,513 ▲ 210% vs 2022 (€ 123,943) Favourable step	€ 368,549 Gross margin 2024: € 368,549 ▼ 4% vs 2023 (€ 384,513) Unfavourable step	€ 364,994 Gross margin 2025: € 364,994 ▼ 1% vs 2024 (€ 368,549) Unfavourable step	▼ 1%
Profit after taxes	€ -233,423 Profit after taxes 2022: € -233,423 First fiscal year in the series	€ 41,654 Profit after taxes 2023: € 41,654 ▲ € 275,077 vs 2022 (€ -233,423) Favourable step	€ 22,641 Profit after taxes 2024: € 22,641 ▼ 46% vs 2023 (€ 41,654) Unfavourable step	€ 21,459 Profit after taxes 2025: € 21,459 ▼ 5% vs 2024 (€ 22,641) Unfavourable step	▼ 5%
Equity	€ -1,025,965 Equity 2022: € -1,025,965 First fiscal year in the series	€ -984,311 Equity 2023: € -984,311 ▲ € 41,654 vs 2022 (€ -1,025,965) Favourable step	€ -961,671 Equity 2024: € -961,671 ▲ € 22,641 vs 2023 (€ -984,311) Favourable step	€ -940,212 Equity 2025: € -940,212 ▲ € 21,459 vs 2024 (€ -961,671) Favourable step	▲ € 21,459
Total debts	€ 1,927,902 Total debts 2022: € 1,927,902 First fiscal year in the series	€ 1,895,798 Total debts 2023: € 1,895,798 ▼ 2% vs 2022 (€ 1,927,902) Favourable step	€ 1,837,191 Total debts 2024: € 1,837,191 ▼ 3% vs 2023 (€ 1,895,798) Favourable step	€ 1,976,018 Total debts 2025: € 1,976,018 ▲ 8% vs 2024 (€ 1,837,191) Unfavourable step	▲ 8%
Cash	€ 1,029 Cash 2022: € 1,029 First fiscal year in the series	€ 2,061 Cash 2023: € 2,061 ▲ 100% vs 2022 (€ 1,029) Favourable step	€ 1,138 Cash 2024: € 1,138 ▼ 45% vs 2023 (€ 2,061) Unfavourable step	€ 10,950 Cash 2025: € 10,950 ▲ € 9,812 vs 2024 (€ 1,138) Favourable step	▲ € 9,812
Retained profit	€ -1,814,339 Retained profit 2022: € -1,814,339 First fiscal year in the series	€ -1,772,685 Retained profit 2023: € -1,772,685 ▲ € 41,654 vs 2022 (€ -1,814,339) Favourable step	€ -1,750,044 Retained profit 2024: € -1,750,044 ▲ € 22,641 vs 2023 (€ -1,772,685) Favourable step	€ -1,728,586 Retained profit 2025: € -1,728,586 ▲ € 21,459 vs 2024 (€ -1,750,044) Favourable step	▲ € 21,459
Bank debt	€ 10,468 Bank debt 2022: € 10,468 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 10,468) Favourable step	€ 2,000 Bank debt 2024: € 2,000 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 2,000) Favourable step	▼ 100%
Balance sheet total	€ 901,937 Balance sheet total 2022: € 901,937 First fiscal year in the series	€ 911,487 Balance sheet total 2023: € 911,487 ▲ 1% vs 2022 (€ 901,937) Unchanged	€ 875,520 Balance sheet total 2024: € 875,520 ▼ 4% vs 2023 (€ 911,487) Unchanged	€ 1,035,806 Balance sheet total 2025: € 1,035,806 ▲ 18% vs 2024 (€ 875,520) Unchanged	▲ 18%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	1.9 Employees (FTE) 2023: 1.9 ▼ 0.1 vs 2022 (2) Unchanged	1.9 Employees (FTE) 2024: 1.9 Unchanged (1.9) Unchanged	1.8 Employees (FTE) 2025: 1.8 ▼ 0.1 vs 2024 (1.9) Unchanged	▼ 0.1

Key figures of RA-SE GENETICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to RA-SE GENETICS?

What happened at RA-SE GENETICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2032 Dany Cornelis stepped down as director. NBB
2032 Thomas Vanden Avenne stepped down as director. NBB
2032 ARL Genetics stepped down as director. NBB
2032 Geert Spincemaille stepped down as director. NBB
2032 Adrian Philip Lawson stepped down as director. NBB
Jun 29, 2026 New annual accounts for financial year 2025: profit of € 21,459 (▼ 5% vs 2024). Source: NBB ↗
2026 Thomas Vanden Avenne became a director. NBB
2026 ARL Genetics became a director. NBB

In short

From € 233,423 loss in 2022 to € 21,459 profit in 2025.

Best year ever: 2023, with € 41,654 profit.

On average € 202,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

RA-SE GENETICS HOLDING 50%

VANDEN AVENNE OOIGEM 50%

The stake of RA-SE GENETICS HOLDING, VANDEN AVENNE OOIGEM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

RA-SE GENETICS

The shares are held by RA-SE GENETICS HOLDING (50%) and VANDEN AVENNE OOIGEM (50%).

Directors

According to the 2025 annual accounts

Dany Cornelis

Director

Also active at: VAN GEMERT, QUALITY MEAT INVESTORS, De Schrijver en Partners

since 2026 · until 2032

Thomas Vanden Avenne

Director

Also active at: SININVEST, VANDEN AVENNE VRIESHUIS

since 2026 · until 2032

ARL Genetics

Director · represented by Robert George Lawson

Also active at: RA-SE GENETICS HOLDING

since 2026 · until 2032

Geert Spincemaille

Director

Also active at: RA-SE GENETICS HOLDING

since 2026 · until 2032

Adrian Philip Lawson

Director

since 2026 · until 2032

Shareholders

RA-SE GENETICS HOLDING

50%

VANDEN AVENNE OOIGEM

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Zwaantjesstraat(O) 12

8710 Wielsbeke

2.342.494.174

Rozebekeplein(Roz) 11

9630 Zwalm

Active since 28 February 2023

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

SININVEST same network

€ 1.1 million gross margin · 2025

VANDEN AVENNE DIERLIJKE PRODUCTIE

€ 101.1 million revenue · 2025

VANDEN AVENNE VRIESHUIS same network

€ 6.4 million revenue · 2025

VANDEN AVENNE OOIGEM same network

€ 425.6 million revenue · 2025

VAN GEMERT same network

€ -1,555 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0479.179.703

VAT number

BE 0479.179.703

Registered office

Zwaantjesstraat(O) 12, 8710 Wielsbeke

Names & denominations

RA-SE GENETICS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 December 2002

Peppol

Active · Active since 7 Oct 2025

Activities · NACE

Fokvarkenshouderijen

Fokvarkenshouderij

View on CBE Public ↗ Annual accounts (NBB) ↗

RA-SE GENETICS

Warning lights

Financials

What happened to RA-SE GENETICS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions